Generic Drug Maker

Jump to

Richcore Lifesciences acquisition marks successful diversification for Laurus Labs, scale-up key

Acquisition of Richcore Lifesciences will give Laurus Labs a foothold in the growing biotechnology sector. Scale-up of the business can be time consuming but can yield meaningful earnings benefits
Cipla eyes strong intl growth; emerging mkts in focus

Cipla aims to focus more on international business and will strengthen its presense in US, Europe. The company is also closely eyeing emerging markets
Canada's Supreme Court strips Viagra patent from Pfizer

Canada's Supreme Court struck down the patent on global pharmaceuticals giant Pfizer Inc's Viagra erectile dysfunction drug on Thursday and opened the door to generic competition.
Cipla, Lupin deny in stake sale talks with Takeda Pharma

Pharmaceutical companies Cipla and Lupin have both strongly denied that they are in talks with Takeda Pharmaceutical Co to sell stake or part of their business, and have said a newspaper report linking the two with the Japanese firm is "baseless."

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Generic Drug Maker

Richcore Lifesciences acquisition marks successful diversification for Laurus Labs, scale-up key

Cipla eyes strong intl growth; emerging mkts in focus

Canada's Supreme Court strips Viagra patent from Pfizer

Cipla, Lupin deny in stake sale talks with Takeda Pharma